BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8469312)

  • 1. Age-related cognitive decline and electroencephalogram slowing in Down's syndrome as a model of Alzheimer's disease.
    Soininen H; Partanen J; Jousmäki V; Helkala EL; Vanhanen M; Majuri S; Kaski M; Hartikainen P; Riekkinen P
    Neuroscience; 1993 Mar; 53(1):57-63. PubMed ID: 8469312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
    Teipel SJ; Alexander GE; Schapiro MB; Möller HJ; Rapoport SI; Hampel H
    Brain; 2004 Apr; 127(Pt 4):811-24. PubMed ID: 14985261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of electroencephalography to detect Alzheimer's disease in Down's syndrome.
    Visser FE; Kuilman M; Oosting J; Overweg J; van Wijk J; van Huffelen AC
    Acta Neurol Scand; 1996 Aug; 94(2):97-103. PubMed ID: 8891053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease.
    Krasuski JS; Alexander GE; Horwitz B; Rapoport SI; Schapiro MB
    Am J Psychiatry; 2002 Jan; 159(1):74-81. PubMed ID: 11772693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of Down's syndrome and Alzheimer's neuropathology on default mode connectivity.
    Wilson LR; Vatansever D; Annus T; Williams GB; Hong YT; Fryer TD; Nestor PJ; Holland AJ; Zaman SH
    Hum Brain Mapp; 2019 Oct; 40(15):4551-4563. PubMed ID: 31350817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The aging of Down's Syndrome subjects].
    Fromage B; Anglade P
    Encephale; 2002; 28(3 Pt 1):212-6. PubMed ID: 12091781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence of cognitive decline in dementia in adults with Down's syndrome.
    Devenny DA; Krinsky-McHale SJ; Sersen G; Silverman WP
    J Intellect Disabil Res; 2000 Dec; 44 ( Pt 6)():654-65. PubMed ID: 11115020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A four year prospective study of age-related cognitive change in adults with Down's syndrome.
    Oliver C; Crayton L; Holland A; Hall S; Bradbury J
    Psychol Med; 1998 Nov; 28(6):1365-77. PubMed ID: 9854278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome.
    Teipel SJ; Schapiro MB; Alexander GE; Krasuski JS; Horwitz B; Hoehne C; Möller HJ; Rapoport SI; Hampel H
    Am J Psychiatry; 2003 Oct; 160(10):1870-8. PubMed ID: 14514503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related neuropsychological deficits in Down's syndrome.
    Thase ME; Tigner R; Smeltzer DJ; Liss L
    Biol Psychiatry; 1984 Apr; 19(4):571-85. PubMed ID: 6234031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of Alzheimer's disease in Down's syndrome assessed by auditory event-related potentials.
    Blackwood DH; St Clair DM; Muir WJ; Oliver CJ; Dickens P
    J Ment Defic Res; 1988 Dec; 32 ( Pt 6)():439-53. PubMed ID: 2976841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olfactory dysfunction in Down's Syndrome.
    Murphy C; Jinich S
    Neurobiol Aging; 1996; 17(4):631-7. PubMed ID: 8832638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome.
    Schapiro MB; Haxby JV; Grady CL; Duara R; Schlageter NL; White B; Moore A; Sundaram M; Larson SM; Rapoport SI
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):766-74. PubMed ID: 2956363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring electrophysiological markers of auditory predictive processes and pathological ageing in adults with Down's syndrome.
    Avancini C; Jennings S; Chennu S; Noreika V; Le A; Bekinschtein TA; Walpert MJ; Clare ICH; Holland AJ; Zaman SH; Ring H
    Eur J Neurosci; 2022 Nov; 56(9):5615-5636. PubMed ID: 35799324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in adults with Down's syndrome: similarities to early cognitive changes in Alzheimer's disease.
    Brugge KL; Nichols SL; Salmon DP; Hill LR; Delis DC; Aaron L; Trauner DA
    Neurology; 1994 Feb; 44(2):232-8. PubMed ID: 8309564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.
    Hanney M; Prasher V; Williams N; Jones EL; Aarsland D; Corbett A; Lawrence D; Yu LM; Tyrer S; Francis PT; Johnson T; Bullock R; Ballard C;
    Lancet; 2012 Feb; 379(9815):528-36. PubMed ID: 22236802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NIH Conference. Alzheimer's disease and Down's syndrome: new insights.
    Cutler NR; Heston LL; Davies P; Haxby JV; Schapiro MB
    Ann Intern Med; 1985 Oct; 103(4):566-78. PubMed ID: 2864010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small cerebral hemispheres in adults with Down's syndrome: contributions of developmental arrest and lesions of Alzheimer's disease.
    de la Monte SM; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1990 Sep; 49(5):509-20. PubMed ID: 2148772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of digestive absorption in four cases of Down's syndrome. Down's syndrome, malnutrition, malabsorption, and Alzheimer's disease.
    Abalan F; Jouan A; Weerts MT; Solles C; Brus J; Sauneron MF
    Med Hypotheses; 1990 Jan; 31(1):35-8. PubMed ID: 2138242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.